What are the treatment options for migraine headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Migraine Headaches

For acute migraine attacks, combination therapy with a triptan plus an NSAID or acetaminophen should be initiated as soon as possible after headache onset as first-line treatment for moderate to severe migraines. 1

Acute Treatment Algorithm

First-Line Options

  1. Mild to Moderate Migraine:

    • NSAIDs (aspirin, diclofenac potassium, ibuprofen 400-600mg, naproxen sodium 500-550mg) 2
    • Acetaminophen (1000mg)
    • Combination of NSAID + acetaminophen
  2. Moderate to Severe Migraine:

    • Triptan + NSAID/acetaminophen combination 1, 2
    • Common triptans with dosing:
      • Sumatriptan: 50-100mg orally, 6mg subcutaneously for severe attacks 2, 3
      • Rizatriptan: 10mg orally 2
      • Zolmitriptan: 2.5-5mg orally 1

Second-Line Options

For patients who don't respond to or cannot tolerate first-line treatments:

  1. CGRP Antagonists (Gepants) 1, 2:

    • Rimegepant
    • Ubrogepant
    • Zavegepant
  2. Ergot Alkaloids 1:

    • Dihydroergotamine (intranasal or injectable)
  3. Ditans 2:

    • Lasmiditan (for patients with contraindications to triptans)

Route of Administration Considerations

  • For severe nausea/vomiting: Use non-oral triptans (subcutaneous, intranasal) with antiemetics 1, 4
  • Subcutaneous sumatriptan: Most effective for rapid pain relief (59% pain-free at 2 hours vs 15% with placebo) 4
  • Oral sumatriptan: 100mg provides better pain relief than 50mg (NNT 3.5 vs 6.1 for pain-free at 2 hours) 5

Preventive Treatment

Consider preventive therapy if:

  • Two or more migraine attacks per month with disability lasting 3+ days
  • Inadequate response to acute treatments
  • Use of acute medications more than twice weekly 2

First-line preventive options:

  • Beta-blockers (propranolol) 1, 2
  • Topiramate
  • Candesartan
  • Amitriptyline
  • CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) 2

Non-Pharmacological Approaches

  • Regular aerobic exercise and strength training 2
  • Maintaining regular sleep schedule
  • Adequate hydration
  • Relaxation techniques and mindfulness
  • Cognitive-behavioral therapy 2
  • Biofeedback combined with relaxation training 1, 2

Important Cautions and Contraindications

  1. Do not use opioids or butalbital for acute migraine treatment 1, 2

  2. Triptan contraindications:

    • Coronary artery disease
    • Uncontrolled hypertension
    • Concurrent use of MAOIs 3, 6
  3. Medication overuse headache risk:

    • Limit triptans to ≤9 days per month
    • Limit NSAIDs to ≤15 days per month 2
  4. Serotonin syndrome risk:

    • Monitor patients taking triptans with SSRIs or SNRIs 6
    • Watch for mental status changes, autonomic instability, neuromuscular symptoms

Special Populations

  • Pregnancy: Metoclopramide for nausea; acetaminophen is safest for pain; sumatriptan may be used under specialist supervision 2
  • Vascular contraindications: Consider NSAIDs, gepants, or ditans instead of triptans 2, 7

Early treatment during the mild pain phase provides significantly better outcomes than treating established attacks with moderate or severe pain 5. The stratified-care approach (assigning treatment based on migraine severity) is superior to the step-care approach (starting with safest, least expensive options) 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Migraine Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sumatriptan (oral route of administration) for acute migraine attacks in adults.

The Cochrane database of systematic reviews, 2012

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.